Crystalcryoglobulinemia-induced kidney disease

Leflot, Sophie; Vekemans, Marie-Christiane; Lambert, Catherine; Demoulin, Nathalie; Aydin, Selda; Leroy, Philippe; Morelle, Johann

doi:10.1016/j.clml.2019.09.535

Crystalcryoglobulinemia-induced kidney disease

Leflot, Sophie

;

Vekemans, Marie-Christiane

;

Lambert, Catherine

;

Demoulin, Nathalie

;

Morelle, Johann

;et.al.

(2019) Clinical Lymphoma Myeloma and Leukemia — Vol. 19, n° 10, p. e325-e326 (2019)

Files

Crystalcryoglobulinemia-includedkidneydisease.pdf

Open Access
Adobe PDF
74.58 KB

Download

Details

Authors

Leflot, SophieUCLouvain
Author
Vekemans, Marie-ChristianeUCLouvain
Author
Lambert, CatherineUCLouvain
Author
Demoulin, NathalieUCLouvain
Author
Aydin, SeldaUCLouvain
Author
Morelle, JohannUCLouvain
Author

Abstract

The spectrum of kidney damage associated with monoclonal gammopathy is wide, and notably encompasses diseases secondary to the abnormal precipitation or deposition of monoclonal immunoglobulins. Crystal(cryo)globulin-induced kidney disease is a rare but dramatic complication of monoclonal gammopathy, characterized by spontaneous crystallization of monoclonal immunoglobulins in the renal and systemic vasculature.

Affiliations

Citations

APA
Chicago
FWB

Leflot, S., Vekemans, M.-C., Lambert, C., Demoulin, N., Aydin, S., Leroy, P., & Morelle, J. (2019). Crystalcryoglobulinemia-induced kidney disease. Clinical Lymphoma Myeloma and Leukemia, 19(10), e325-e326. https://doi.org/10.1016/j.clml.2019.09.535 (Original work published 2019)